Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

類似資料

• Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
  著者:: Holmgaard, Rikke B, 等
  出版事項: (2014)
• Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
  著者:: Holmgaard, Rikke B., 等
  出版事項: (2013)
• Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
  著者:: Holmgaard, Rikke B, 等
  出版事項: (2013)
• Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
  著者:: Lesokhin, Alexander M., 等
  出版事項: (2013)
• Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
  著者:: Zamarin, Dmitriy, 等
  出版事項: (2014)